TenNor Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$42.3M
- Investors
-
14
TenNor Therapeutics General Information
Description
Developer of innovative drugs for diseases associated with bacterial infections and bacterial dysbiosis. The company's platform offers a multi-targeting product development portfolio for treating diseases associated with gastrointestinal tract infection and dysbiosis, medical device infections, and bacterial vaginosis, enabling users to get new drugs for the treatment of various diseases with unmet needs.
Contact Information
Website
www.tennorx.comCorporate Office
- Room 701, Building B7, Biopharmaceutical Industrial Park
- No. 218 Xinghu Street
- Suzhou, Jiangsu 215123
- China
Corporate Office
- Room 701, Building B7, Biopharmaceutical Industrial Park
- No. 218 Xinghu Street
- Suzhou, Jiangsu 215123
- China
TenNor Therapeutics Timeline
TenNor Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series E) | 24-Sep-2024 | $42.3M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series D1) | 05-Jan-2023 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC (Series D) | 25-Feb-2022 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series C) | 30-Jun-2020 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series C) | 18-May-2016 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series B) | 21-Nov-2013 | $7M | $7M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 22-May-2013 | Completed | Startup |
TenNor Therapeutics Comparisons
Industry
Financing
Details
TenNor Therapeutics Competitors (16)
One of TenNor Therapeutics’s 16 competitors is Ona Therapeutics, a Venture Capital-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| StemiRNA Therapeutics Biotech | Venture Capital-Backed | Shanghai, China | ||||
| Loxo Oncology | Formerly VC-backed | Stamford, CT | ||||
| Cardurion | Venture Capital-Backed | Burlington, MA | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
TenNor Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TenNor Therapeutics Patents
TenNor Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240082229-A1 | Methods for preventing or treating h. pylori infection | Active | 18-Aug-2022 | ||
| US-12005050-B2 | Methods for preventing or treating h. pylori infection | Active | 18-Aug-2022 | ||
| US-20240000755-A1 | Pharmaceutical composition comprising sulbactam and avibactam, and application thereof | Pending | 27-Aug-2021 | ||
| JP-2022548067-A | Penam derivatives for treating bacterial infections | Active | 11-Sep-2019 | ||
| US-20210070774-A1 | Penam derivatives for treating bacterial infections | Active | 11-Sep-2019 | A61P31/04 |
TenNor Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TenNor Therapeutics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AMR Action Fund | Impact Investing | Minority | ||
| Zhongshan Finance Investment | Venture Capital | Minority | ||
| Broad Resources | PE/Buyout | Minority | ||
| Bison Capital Financial Holdings | Venture Capital | Minority | ||
| Galaxy Holdings | Growth/Expansion | Minority |
TenNor Therapeutics FAQs
-
When was TenNor Therapeutics founded?
TenNor Therapeutics was founded in 2013.
-
Where is TenNor Therapeutics headquartered?
TenNor Therapeutics is headquartered in Suzhou, China.
-
What is the size of TenNor Therapeutics?
TenNor Therapeutics has 38 total employees.
-
What industry is TenNor Therapeutics in?
TenNor Therapeutics’s primary industry is Drug Discovery.
-
Is TenNor Therapeutics a private or public company?
TenNor Therapeutics is a Private company.
-
What is TenNor Therapeutics’s current revenue?
The current revenue for TenNor Therapeutics is .
-
How much funding has TenNor Therapeutics raised over time?
TenNor Therapeutics has raised $118M.
-
Who are TenNor Therapeutics’s investors?
AMR Action Fund, Zhongshan Finance Investment, Broad Resources, Bison Capital Financial Holdings, and Galaxy Holdings are 5 of 14 investors who have invested in TenNor Therapeutics.
-
Who are TenNor Therapeutics’s competitors?
Ona Therapeutics, StemiRNA Therapeutics Biotech, Loxo Oncology, Cardurion, and Genentech are some of the 16 competitors of TenNor Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
